Islet cell function in type 1 and type 2 diabetes

被引:0
|
作者
Hao, W [1 ]
Palmer, JP [1 ]
机构
[1] Dept Vet Affairs, Puget Sound Hlth Care Syst, Seattle, WA 98108 USA
来源
JOURNAL OF CLINICAL LIGAND ASSAY | 1998年 / 21卷 / 03期
关键词
diabetes; insulin; C-peptide; glucose; arginine; glucagon; insulin sensitivity; beta cell function; insulin secretion;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The primary hormone controlling glucose metabolism is insulin. A deficiency in insulin secretion is a central defect in the pathophysiology of both type 1 and type 2 diabetes. In this review we discuss the abnormalities of insulin secretion characteristic of both forms of diabetes. We describe most of the commonly employed tests of beta cell function and explore their relative advantages and disadvantages. Usually, there is a trade-off between the complexity of the test and the amount of information obtained. For example, measuring insulin or C-peptide during the fasting state provides far less information on total beta cell functional capacity than does dynamic beta cell testing at different glucose levels using several intravenous beta cell secretagogues. Since insulin and C-peptide are the primary measurements used during beta cell testing, a few caveats are provided regarding both of these assays and the interpretation of results.
引用
收藏
页码:309 / 317
页数:9
相关论文
共 50 条
  • [21] Microfluidic Technology for Evaluating and Preserving Islet Function for Islet Transplant in Type 1 Diabetes
    Xing, Yuan
    Li, Love
    Yu, Xiaoyu
    Fox, Emily Grace
    Wang, Yong
    Oberholzer, Jose
    CURRENT TRANSPLANTATION REPORTS, 2022, 9 (04) : 287 - 296
  • [22] Update on islet-cell transplantation for type 1 diabetes
    Hopkins, KD
    LANCET, 2002, 359 (9324): : 2172 - 2172
  • [23] Request for applications: Islet cell replacement in type 1 diabetes
    Campbell, S
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2004, : 23 - 24
  • [24] Heterogeneity of islet cell physiology in the pathogenesis of type 1 diabetes
    Cohrs, C. M.
    Avila, A. K. Mojica
    Speier, S.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S52 - S52
  • [25] Islet cell transplantation for the treatment of type 1 diabetes in the USA
    Ikemoto, Tetsuya
    Noguchi, Hirofumi
    Shimoda, Masayuki
    Naziruddin, Bashoo
    Jackson, Andrew
    Tamura, Yoshiko
    Fujita, Yasutaka
    Onaca, Nicholas
    Levy, Marlon F.
    Matsumoto, Shinichi
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2009, 16 (02): : 118 - 123
  • [26] Microfluidic Technology for Evaluating and Preserving Islet Function for Islet Transplant in Type 1 Diabetes
    Yuan Xing
    Love Li
    Xiaoyu Yu
    Emily Grace Fox
    Yong Wang
    José Oberholzer
    Current Transplantation Reports, 2022, 9 : 287 - 296
  • [27] An audit of islet cell autoantibody testing for type 1 diabetes
    Courtney, C.
    Mohamed, N.
    Weston, P. J.
    DIABETIC MEDICINE, 2021, 38
  • [28] Islet (cell) transplantation in type-1 diabetes patients
    Brendel, M. D.
    Ludwig, B.
    Eckhard, M.
    Bretzel, R. G.
    DIABETOLOGE, 2010, 6 (05): : 357 - 365
  • [29] Novel type 1 and type 2 diabetes susceptibility genes influence development of islet autoimmunity and type 1 diabetes in children of parents with type 1 diabetes
    Winkler, C.
    Bonifacio, E.
    Grallert, H.
    Lauber, C.
    Trovesi, E.
    Illig, T.
    Ziegler, A. -G.
    DIABETOLOGIA, 2010, 53 : S120 - S120
  • [30] Influence of Vitamin D on Islet Autoimmunity and Beta-Cell Function in Type 1 Diabetes
    Infante, Marco
    Ricordi, Camillo
    Sanchez, Janine
    Clare-Salzler, Michael J.
    Padilla, Nathalia
    Fuenmayor, Virginia
    Chavez, Carmen
    Alvarez, Ana
    Baidal, David
    Alejandro, Rodolfo
    Caprio, Massimiliano
    Fabbri, Andrea
    NUTRIENTS, 2019, 11 (09)